A Study of Two Forms of Pentamidine in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

To compare parenteral versus inhaled pentamidine in patients with documented Pneumocystis carinii pneumonia (PCP) with AIDS.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: LyphoMed
• Treatments: Pentamidine

Criteria

Exclusion Criteria

Co-existing Condition:

Patients with the following are excluded:

• Previous history of adverse reaction to pentamidine.

• History of asthma.

• Pulmonary Kaposi's sarcoma.

Patients with the following are excluded:

• Previous history of adverse reaction to pentamidine.

• History of asthma.

• Pulmonary Kaposi's sarcoma.

• Inability to understand the consent procedure.

All patients hospitalized at Cedars-Sinai Medical Center with AIDS and possible Pneumocystis carinii pneumonia (PCP) will be eligible.

• Patients with HIV antibody or AIDS and a clinical presentation suggesting PCP are eligible.